Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1753 | Thyroid cancer | ICEECE2012

The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor gamma in thyroid cancer cells

Chu R , van Hasselt C , Chen G

Both of peroxisome proliferator-activated receptor gamma (PPARγ) and estrogen receptor (ER) contribute to the development of thyroid cancer. Previously, the activation of ERα was found to promote the proliferation of thyroid cancer cells, whereas activation of either ERβ or PPARγ resulted in apoptosis of thyroid cancer cells. Furthermore, a transactivation between ER and PPARγ was reported in estrogen-responsive malignancy, such as breast cancer. Howev...

ea0011p138 | Clinical case reports | ECE2006

Resolution of diagnostic uncertainties with DAX-1 gene mutation analysis

Arundel P , Fisher R , Chu C , Alvi S

Mutations in the DAX-1 gene are well described in patients with adrenal hypoplasia congenita (AHC) and hypogonadotropic hypogonadism but can be a useful tool in the elucidation of unusual or difficult cases of adrenal insufficiency. As the clinical presentation of congenital adrenal hyperplasia and AHC can be clinically identical, diagnosis in the neonate often depends on the levels of 17-hydroxyprogesterone (17-OHP). If these are unavailable or non-diagnostic, gene analysis c...